Clinical correlation of nonalcoholic fatty liver disease in a Chinese taxi drivers population in Taiwan: Experience at a teaching hospital

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Tung, Tao Hsin ^a,b,c   Chang, Tsung Hung ^d   Chiu, Wei Hsiu ^a,e,f,g   Lin, Tzu Han ^a,b   Shih, Hui Chuan ^d   Chang, Ming Huei ^a,b   Liu, Jorn Hon ^a,e  

^a CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c Kang Ning Junior College of Medical Care and Management   (Taiwan)

^d KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f Central Clinic Hospital   (Taiwan)

^g Chung Shan Hospital   (Taiwan)

Author keywords

gender difference; nonalcoholic fatty liver disease; prevalence; taxi drivers

Indexed keywords

EID: 80052115106     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-315     Document Type: Article

References (33)

1. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. Barshop NJ, Sirlin CB, Schwimmer JB, Lavine JE, Aliment Pharmacol Ther 2008 28 13 24 10.1111/j.1365-2036.2008. 03703.x 18397387 (Pubitemid 351782810)
2. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase Levels: A role for insulin resistance and diabetes. Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, et al. Hepatology 2008 48 792 798 18752331
3. Epidemiological analysis of alcoholic and non-alcoholic fatty liver in Shanxi and Gansu province. Yan H, Luo JY, Zhou XY, Weichang Bingxue he Ganbing Xue Zazhi 2007 16 347 350
4. Epidemiological survey on fatty liver in rural area of Guangdong province. Ma JX, Zhou YJ, Chen PY, Nie YQ, Shi SL, Li YY, Zhongguo Gonggong Weisheng 2007 23 874 876
5. Asia-Pacific Working Party for NAFLD. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A, J Gastroenterol Hepatol 2007 22 794 800 10.1111/j.1440-1746.2007.04952.x 17498218 (Pubitemid 46911036)
6. A commumity-based epidemiological syudy of elevated serum alanine aminotransferase levels in Kinmen, Taiwan. Liu CM, Tung TH, Liu JH, Chen VT, Lin CH, Hsu CT, Chou P, World J Gastroenterol 2005 11 1616 1622 15786537 (Pubitemid 40520801)
7. Epidemiology of fatty liver in an islander population of China: a population-based case-control study. Dai HF, Shen Z, Yu CH, Zhang XC, Li YM, Hepatobiliary Pancreat Dis Int 2008 4 373 378
8. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Lazo M, Clark JM, Semin Liver Dis 2008 28 339 350 10.1055/s-0028-1091978 18956290
9. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Neuschwander-Tetri BA, Caldwell SH, Hepatotology 2003 37 1202 1219 10.1053/jhep.2003.50193 (Pubitemid 36538699)
10. Global changes in liver disease. Williams R, Hepatology 2006 44 521 526 10.1002/hep.21347 16941687 (Pubitemid 44433707)
11. Epidemiology of non-alcoholic fatty liver disease in China. Fan JG, Farrell GC, J Hepatol 2009 50 204 210 10.1016/j.jhep.2008.10.010 19014878
12. Prevalence of fatty liver disease and its risk factors in the population of South China. Zhou YJ, Li yy, Nie YQ, Ma JX, Lu LG, Shi SL, et al. World J Gastroenterol 2007 13 6419 6424 10.3748/wjg.13.6419 18081233
13. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. Fan JG, Zhu j, Li XJ, Chen L, Li L, Dai F, et al. J Hepatol 2005 43 508 514 10.1016/j.jhep.2005.02.042 16006003 (Pubitemid 41111434)
14. Steatohepatitis studies in China. Fan JG, Shijie Huaren Xiaohua Zazhi 2001 9 6 10 (Pubitemid 32101982)
15. Nonalcoholic steatohepatitis. Sheth SG, Gordon FD, Chopra S, Ann Intern Med 1997 126 137 145 9005748 (Pubitemid 27058588)
16. Gender, fatty liver and GGT. Carulli L, Lonardo A, Lombardini S, Marchesini G, Loria P, Hepatology 2006 44 278 279 10.1002/hep.21218 16799969 (Pubitemid 44049160)
17. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Targher G, Bertolini L, Padovani R, et al. Diabetes Care 2007 30 1212 1218 10.2337/dc06-2247 17277038 (Pubitemid 46684650)
18. Non-alcoholic fatty liver disease: current concepts and management strategies. Day CP, Clin Med 2006 6 19 25 16521351
19. Pathophysiology of non-alcoholic steatohepatitis. McCullough AJ, J Clin Gastroenterol 2006 40 17 S29 16540762
20. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease. Wong VW, Hui AY, Tsang SW, et al. Aliment Pharmacol Ther 2006 24 1215 1222 10.1111/j.1365-2036.2006. 03112.x 17014580 (Pubitemid 44427509)
21. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Angulo P, Hui JM, Marchesini G, et al. Hepatology 2007 45 846 854 10.1002/hep.21496 17393509 (Pubitemid 46631552)
22. Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town. Pendino GM, Mariano A, Surace P, et al. Hepatology 2005 41 1151 1159 10.1002/hep.20689 15841464 (Pubitemid 40593924)
23. Evaluation of abnormal liver-enzyme results in asymptomatic patients. Pratt DS, Kaplan MM, N Engl J Med 2000 342 1266 1271 10.1056/NEJM200004273421707 10781624 (Pubitemid 30235957)
24. The important of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers. Fan JG, Li f, Cai XB, Peng YD, Ao QH, Gao Y, J Gastroenterol Hepatol 2007 22 663 668 10.1111/j.1440-1746.2007.04892.x 17444853 (Pubitemid 46608389)
25. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, et al. J Gastroenterol Hepatol 2007 22 1482 1489 10.1111/j.1440-1746. 2006.04615.x 17716352 (Pubitemid 47274571)
26. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Alberti KGMM, Zimmet P, Shaw J, Diabet Med 2006 23 469 480 10.1111/j.1464-5491.2006.01858.x 16681555
27. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Hamaguchi M, Kojima T, Takeda N, et al. Ann Intern Med 2005 143 722 728 16287793
28. Asians are different from Caucasians and from each other in their body mass index/body fat percent relationship. Deurenberg P, Deurenberg-Yap M, Guricci S, Obes Rev 2002 3 141 146 10.1046/j.1467-789X.2002.00065.x 12164465 (Pubitemid 34815232)
29. Intravenous load of fructose and fructose 1,6-diphosphate: effects on uricemia in patients with nonalcoholic liver disease. Loguercio C, Nardone G, Sicolo P, Cuomo R, Del Vecchio C, Budillon G, Am J Gastroenterology 1996 91 559 564 (Pubitemid 26084441)
30. A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients. Bruckert E, Giral P, Ratziu V, Poynard T, Chapman MJ, Opolon P, Turpin G, Metabolism:Clinical & Experimental 2002 51 1071 1076 21887787
31. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. Strauss S, Gavish E, Gottlieb P, Katsnelson L, Am J Roentgenol 2007 189 320 W323 10.2214/AJR.07.2123 (Pubitemid 350174809)
32. Sample Size Calculations in Clinical Research. Chow SC, Shao J, Wang H, Marcel Dekker. New York 2003
33. Statistical Methods for Rates and Proportions. Fleiss JL, Levin B, Paik MC, John Wiley & Sons. New York Third 2003